Walleye Capital
REGN icon

Walleye Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Walleye Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
22,596
+18,574
+462% +$12.6M 0.05% 358
2026
Q1 		$3.11M Sell
4,022
-31,478
-89% -$24.1M 0.01% 1124
2025
Q4 		$27.4M Sell
35,500
-51,974
-59% -$35.3M 0.08% 184
2025
Q3 		$49.2M Buy
87,474
+25,703
+42% +$14.5M 0.18% 65
2025
Q2 		$32.4M Buy
61,771
+53,575
+654% +$29.9M 0.13% 104
2025
Q1 		$5.2M Sell
8,196
-1,878
-19% -$1.29M 0.02% 758
2024
Q4 		$7.18M Buy
10,074
+2,807
+39% +$2.36M 0.02% 844
2024
Q3 		$7.64M Buy
7,267
+2,367
+48% +$2.63M 0.02% 866
2024
Q2 		$5.15M Buy
4,900
+425
+9% +$412K 0.01% 1260
2024
Q1 		$4.31M Buy
4,475
+2,425
+118% +$2.31M 0.01% 1403
2023
Q4 		$1.8M Buy
+2,050
New +$1.69M ﹤0.01% 1868
2023
Q3 		– Sell
-21,673
Closed -$17M – 5246
2023
Q2 		$15.6M Buy
21,673
+21,473
+10,737% +$16.6M 0.06% 231
2023
Q1 		$164K Buy
+200
New +$151K ﹤0.01% 2615
2021
Q3 		– Sell
-3,415
Closed -$1.91M – 1773
2021
Q2 		$1.91M Buy
+3,415
New +$1.73M 0.07% 257
2020
Q4 		– Sell
-589
Closed -$330K – 1081
2020
Q3 		$330K Buy
+589
New +$357K 0.04% 482
2020
Q2 		– Sell
-468
Closed -$228K – 905
2020
Q1 		$228K Buy
468
+78
+20% +$32.2K 0.05% 404
2019
Q4 		$146K Buy
390
+380
+3,800% +$128K 0.01% 1252
2019
Q3 		$3K Hold
10
– – ﹤0.01% 1826
2019
Q2 		$3K Sell
10
-443
-98% -$147K ﹤0.01% 1651
2019
Q1 		$186K Buy
+453
New +$187K 0.03% 802

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Walleye Capital's REGN Position: Q2 2026 in Review

Walleye Capital increased its Regeneron Pharmaceuticals (REGN) stake by 462% in Q2 2026, buying an estimated $12.6M and bringing the position to 22,596 shares worth $14.1M. The position accounts for 0.05% of the portfolio, ranked #358.

Walleye Capital first reported a position in REGN in Q1 2019 and has held it in 20 quarters since. The position peaked at $49.2M in Q3 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Walleye Capital held 22,596 shares of Regeneron Pharmaceuticals worth $14.1M as of Q2 2026.
  • Walleye Capital bought 18,574 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.6M.
  • Regeneron Pharmaceuticals made up 0.05% of Walleye Capital's portfolio in Q2 2026, its #358 holding.
  • Walleye Capital first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 20 quarters since.
  • Walleye Capital's Regeneron Pharmaceuticals position peaked at $49.2M in Q3 2025.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.